Suppr超能文献

代谢综合征与亚临床甲状腺功能减退症的发病率增加有关——一项队列研究。

Metabolic syndrome is associated with an increased incidence of subclinical hypothyroidism - A Cohort Study.

机构信息

Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan.

Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.

出版信息

Sci Rep. 2017 Jul 28;7(1):6754. doi: 10.1038/s41598-017-07004-2.

Abstract

Prior cross-sectional analyses have demonstrated an association between subclinical hypothyroidism and metabolic syndrome and selected components. However, the temporal relation between metabolic syndrome and declining thyroid function remains unclear. In a prospective study, an unselected cohort of 66,822 participants with and without metabolic syndrome were followed. A proportional hazards regression model was used to estimate hazard ratios (HRs) and 95% CIs for hypothyroidism. Exploratory analyses for the relation between components of metabolic syndrome and declining thyroid function were also undertaken. During an average follow-up of 4.2 years, the incident rates for subclinical hypothyroidism were substantially higher in participants who began the study with metabolic syndrome compared with metabolically normal controls. After controlling for risk factors, patients with metabolic syndrome were at a 21% excess risk of developing subclinical hypothyroidism (adjusted HR 1.21; 95% CI 1.03-1.42). When individual components were analyzed, an increased risk of subclinical hypothyroidism was associated with high blood pressure (1.24; 1.04-1.48) and high serum triglycerides (1.18; 1.00-1.39), with a trend of increasing risk as participants had additional more components. Individuals with metabolic syndrome are at a greater risk for developing subclinical hypothyroidism, while its mechanisms and temporal consequences of this observation remain to be determined.

摘要

先前的横断面分析表明,亚临床甲状腺功能减退症与代谢综合征和某些特定成分之间存在关联。然而,代谢综合征与甲状腺功能减退之间的时间关系尚不清楚。在一项前瞻性研究中,对有和没有代谢综合征的 66822 名未选择的参与者进行了随访。使用比例风险回归模型来估计甲状腺功能减退的风险比(HR)和 95%置信区间(CI)。还进行了代谢综合征成分与甲状腺功能减退之间关系的探索性分析。在平均 4.2 年的随访期间,与代谢正常对照组相比,开始研究时患有代谢综合征的参与者中亚临床甲状腺功能减退的发生率明显更高。在控制了危险因素后,患有代谢综合征的患者发生亚临床甲状腺功能减退的风险增加了 21%(调整后的 HR 为 1.21;95%CI 为 1.03-1.42)。当分析各个成分时,亚临床甲状腺功能减退的风险与高血压(1.24;1.04-1.48)和高血清甘油三酯(1.18;1.00-1.39)相关,随着参与者具有更多的成分,风险呈上升趋势。患有代谢综合征的个体发生亚临床甲状腺功能减退的风险更高,而其机制和观察结果的时间后果仍有待确定。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20d8/5533753/d1f9f468ed36/41598_2017_7004_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验